Synthesis and evaluation of macromolecule-bound derivatives of a peptidyl-1-β-D-arabinofuranosylcytosine prodrug

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Macromolecule-bound Val-Leu-Lys-ara-C (1) prodrugs were synthesized with spacers (-HN-(CH2)x-CO-; x =1,3,5) beNeen the dextran carrier (T-70) and 1, in order to achieve a sustained-release drug delivery system dextran-NH-(CH2)x:1,3,5-CO-Val-Leu-Lys-ara-C (5, 6 and 7). The conjugation increased the stability of 1 in aqueous buffer solutions by three times (t1/2 53.0 h, pH 7.4). The length of spacer also regulated the rate of hydrolysis of the prodrugs in serum. The shortest spacer (-HN-(CH2)-CO-, (2)) in 5 provided the best protection of 1 against the hydrolyzing ability of proteinase-a2-macroglobulin complexes, increasing its half-life approximately 30-fold. The conjugation procedure resulted in a growth arrest ability for macromolecular-bound prodrugs 5, 6 and 7 against L1210 with IC50 of 0.01 μM in vitro, which is significantly lower than that of other ara-C-macromolecule conjugates. 5 and 6 arrested cell growth in a broader range of concentration, between 1 × 10-5 -1.0 μM, than ara-C could.

Original languageEnglish
Pages (from-to)83-89
Number of pages7
JournalDrug Metabolism Letters
Volume2
Issue number2
DOIs
Publication statusPublished - Apr 1 2008

Keywords

  • Ara-C
  • Dextran
  • Macromolecule conjugates
  • Prodrug

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Clinical Biochemistry
  • Biochemistry, medical
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Synthesis and evaluation of macromolecule-bound derivatives of a peptidyl-1-β-D-arabinofuranosylcytosine prodrug'. Together they form a unique fingerprint.

  • Cite this